Skip to main content
XCUR
NASDAQ Life Sciences

生物科技公司Exicure与Adbiotech合作开发Burixafor

feedReported by Reuters
Sentiment info
Positive
Importance info
8
Price
$3.98
Mkt Cap
$23.188M
52W Low
$3.101
52W High
$12.652
Market data snapshot near publication time

summarizeSummary

生物科技公司Exicure宣布与Adbiotech签署了联合开发协议,用于开发其药物候选物Burixafor (Gpc-100)。这一合作对于Exicure来说是一个重大的积极发展,尤其是在最近披露了严峻的现金状况和对公司持续经营能力存在重大疑虑之后。该协议可能为Burixafor提供关键资源、专业知识和验证,可能缓解一些财务压力,并推进药物的开发。交易者将关注该合作的财务条款细节及其对公司流动性和产品管线进展的影响。

在该公告发布时,XCUR的交易价格为$3.98,交易所为NASDAQ,所属行业为Life Sciences,市值约为$2318.8万。 52周交易区间为$3.10至$12.65。 这则新闻被评估为积极市场情绪,重要性评分为8/10。 来源:Reuters。


show_chartPrice Chart

Share this article

Copied!

feed XCUR - Latest Insights

XCUR
Apr 22, 2026, 7:57 PM EDT
Source: Reuters
Importance Score:
8
XCUR
Apr 10, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
XCUR
Apr 02, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
XCUR
Mar 27, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
XCUR
Mar 27, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
7
XCUR
Mar 25, 2026, 4:42 PM EDT
Filing Type: 10-K
Importance Score:
9
XCUR
Mar 25, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
9
XCUR
Mar 25, 2026, 4:18 PM EDT
Source: GlobeNewswire
Importance Score:
9
XCUR
Feb 17, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
8
XCUR
Feb 10, 2026, 4:25 PM EST
Filing Type: 8-K
Importance Score:
9